Rockel Christoph, Hartung Thomas
Biochemical Pharmacology, University of Konstanz Konstanz, Germany.
Front Pharmacol. 2012 Apr 17;3:56. doi: 10.3389/fphar.2012.00056. eCollection 2012.
Fifty years after the elucidation of lipopolysaccharides (LPS, endotoxin) as the principal structure of Gram-negative bacteria activating the human immune system, its Gram-positive counterpart is still under debate. Pyrogen tests based on the human monocyte activation have been validated for LPS detection as an alternative to the rabbit test and, increasingly, the limulus amebocyte lysate test. For full replacement, international validations with non-endotoxin pyrogens are in preparation. Following evidence-based medicine approaches, a systematic review of existing evidence as to the structural nature of the Gram-positive pyrogen was undertaken. For the three major constituents suggested, i.e., peptidoglycan, lipoteichoic acids (LTA), and bacterial lipoproteins (LP), the questions to be answered and a search strategy for relevant literature was developed, starting in MedLine. The evaluation was based on the Koch-Dale criteria for a mediator of an effect. A total of 380 articles for peptidoglycan, 391 for LP, and 285 for LTA were retrieved of which 12, 8, and 24, respectively, fulfilled inclusion criteria. The compiled data suggest that for peptidoglycan two Koch-Dale criteria are fulfilled, four for LTA, and two for bacterial LP. In conclusion, based on the best currently available evidence, LTA is the only substance that fulfills all criteria. LTA has been isolated from a large number of bacteria, results in cytokine release patterns inducible also with synthetic LTA. Reduction in bacterial cytokine induction with an inhibitor for LTA was shown. However, this systematic review cannot exclude the possibility that other stimulatory compounds complement or substitute for LTA in being the counterpart to LPS in some Gram-positive bacteria.
在阐明脂多糖(LPS,内毒素)是激活人类免疫系统的革兰氏阴性菌的主要结构50年后,其革兰氏阳性对应物仍存在争议。基于人单核细胞激活的热原检测已被验证可用于LPS检测,作为兔热原检测以及越来越多使用的鲎试剂检测的替代方法。为了完全替代,正在准备使用非内毒素热原进行国际验证。遵循循证医学方法,对革兰氏阳性热原的结构性质的现有证据进行了系统综述。对于提出的三种主要成分,即肽聚糖、脂磷壁酸(LTA)和细菌脂蛋白(LP),制定了要回答的问题以及从MedLine开始的相关文献检索策略。评估基于效应介质的科赫 - 戴尔标准。分别检索到380篇关于肽聚糖的文章、391篇关于LP的文章和285篇关于LTA的文章,其中分别有12篇、8篇和24篇符合纳入标准。汇总的数据表明,肽聚糖满足两条科赫 - 戴尔标准,LTA满足四条,细菌LP满足两条。总之,基于目前可得的最佳证据,LTA是唯一满足所有标准的物质。LTA已从大量细菌中分离出来,其导致的细胞因子释放模式也可由合成LTA诱导产生。已显示使用LTA抑制剂可减少细菌细胞因子诱导。然而,这项系统综述不能排除在某些革兰氏阳性菌中,其他刺激化合物作为LPS的对应物补充或替代LTA的可能性。